Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank80
3Y CAGR+7.1%
5Y CAGR-17.0%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+7.1%/yr
vs -6.0%/yr prior
5Y CAGR
-17.0%/yr
Recent acceleration
Acceleration
+13.1pp
Accelerating
Percentile
P80
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 21.89% |
| Q2 2025 | 9.93% |
| Q1 2025 | -103.89% |
| Q4 2024 | 2.49% |
| Q3 2024 | -15.94% |
| Q2 2024 | 32.25% |
| Q1 2024 | 8.80% |
| Q4 2023 | 19.44% |
| Q3 2023 | -15.11% |
| Q2 2023 | 24.02% |
| Q1 2023 | -8.10% |
| Q4 2022 | -11.14% |
| Q3 2022 | 17.83% |
| Q2 2022 | -0.97% |
| Q1 2022 | -12.70% |
| Q4 2021 | -31.78% |
| Q3 2021 | -1025.32% |
| Q2 2021 | 108.14% |
| Q1 2021 | -42.40% |
| Q4 2020 | -19.40% |
| Q3 2020 | 55.72% |
| Q2 2020 | 8.39% |
| Q1 2020 | -8.89% |
| Q4 2019 | -100.08% |
| Q3 2019 | 27.96% |
| Q2 2019 | 21.82% |
| Q1 2019 | -101.52% |
| Q4 2018 | -30.76% |
| Q3 2018 | -63.43% |
| Q2 2018 | 27.57% |
| Q1 2018 | 0.00% |